Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients
N Meidenbauer, J Marienhagen, M Laumer… - The Journal of …, 2003 - journals.aai.org
Adoptive T cell therapy has been successfully used for treatment of viral and malignant
diseases. However, little is known about the fate and trafficking of transferred Ag-specific T …
diseases. However, little is known about the fate and trafficking of transferred Ag-specific T …
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
Dendritic cell (DC)-based therapy has proved to be effective in patients with a variety of
malignancies. However, an optimal immunization protocol using DCs and the best means …
malignancies. However, an optimal immunization protocol using DCs and the best means …
Collagen fiber structure guides 3D motility of cytotoxic T lymphocytes
Lymphocyte motility is governed by a complex array of mechanisms, and highly dependent
on external microenvironmental cues. Tertiary lymphoid sites in particular have unique …
on external microenvironmental cues. Tertiary lymphoid sites in particular have unique …
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Abstract Helper (CD4+) T cells perform direct therapeutic functions and augment responses
of cells such as cytotoxic (CD8+) T cells against a wide variety of diseases and pathogens …
of cells such as cytotoxic (CD8+) T cells against a wide variety of diseases and pathogens …
Introducing a mouse model for pre‐eclampsia: adoptive transfer of activated Th1 cells leads to pre‐eclampsia‐like symptoms exclusively in pregnant mice
AC Zenclussen, S Fest, R Joachim… - European journal of …, 2004 - Wiley Online Library
Pre‐eclampsia (PE) is the most severe pregnancy‐related disease, leading to high maternal
and fetal morbidity/mortality. Immunological imbalances associated with endothelial cell …
and fetal morbidity/mortality. Immunological imbalances associated with endothelial cell …
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells
V Vignard, B Lemercier, A Lim… - The Journal of …, 2005 - journals.aai.org
In this study, we report the adoptive transfer of highly tumor-reactive Melan-A-specific T cell
clones to patients with metastatic melanoma, and the follow-up of these injected cells. These …
clones to patients with metastatic melanoma, and the follow-up of these injected cells. These …
Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
E Blümel, S Munir Ahmad, C Nastasi… - …, 2020 - Taylor & Francis
Staphylococcus aureus and its toxins have been linked to disease progression and mortality
in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role …
in advanced stages of cutaneous T-cell lymphoma (CTCL). CD8+ T cells play a crucial role …
ImmunoMap: a bioinformatics tool for T-cell repertoire analysis
Despite a dramatic increase in T-cell receptor (TCR) sequencing, few approaches
biologically parse the data in a fashion that both helps yield new information about immune …
biologically parse the data in a fashion that both helps yield new information about immune …
An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity
K Fischer, R Andreesen, A Mackensen - Journal of immunological methods, 2002 - Elsevier
The cytotoxic activity of T lymphocytes, natural killer and lymphokine-activated killer cells is
usually tested by radioactive assays, which detect the release of cytoplasmic contents after …
usually tested by radioactive assays, which detect the release of cytoplasmic contents after …
In vitro priming of tumor-specific cytotoxic T lymphocytes using allogeneic dendritic cells derived from the human MUTZ-3 cell line
SJAM Santegoets, MWJ Schreurs… - Cancer Immunology …, 2006 - Springer
The adoptive transfer of in vitro-induced and expanded tumor-specific cytotoxic T
lymphocytes (CTL) presents a promising immunotherapeutic approach for the treatment of …
lymphocytes (CTL) presents a promising immunotherapeutic approach for the treatment of …